Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation

Toshinobu Nishimura, Shin Kaneko, Ai Kawana‐Tachikawa, +18

Cell stem cell

T-regulatory CellImmunologyAntigen ProcessingAutoimmunityT Cell Immunity +4

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome

Tsunehisa Kaku, Hiroyuki Yoshikawa, Hitoshi Tsuda, +13

Cancer Letters

Gynecological SurgeryCentral Pathologic ReviewConservative TherapyGynecologyMenstrual Cycle +4

Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination

Renata M. Martin, Kazuya Ikeda, M. Kyle Cromer, +18

Cell stem cell

Induced Pluripotent Stem CellEngineeringMedicineGenetic EngineeringStem Cell Research +11

Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice

Fumikiyo Nagawa, Natsuko Kishishita, Kazumichi Shimizu, +12

Nature Immunology

BiologyGeneticsCopy ChoiceGene StructureGenetic Engineering +9

Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease

Mark P. Chao, Andrew J. Gentles, Susmita Chatterjee, +15

Cell stem cell

Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyImmunologyPathology +5

Inhibition of Apoptosis Overcomes Stage-Related Compatibility Barriers to Chimera Formation in Mouse Embryos

Hideki Masaki, Megumi Kato‐Itoh, Yusuke Takahashi, +12

Cell stem cell

Developmental BiologyChimera FormationGeneticsApoptosisMouse Embryos +5

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

Renata M. Martin, Jonas L. Fowler, M. Kyle Cromer, +6

Nature Communications

Determination of a Normal Level of Serum CA125 in Postmenopausal Women as a Tool for Preoperative Evaluation and Postoperative Surveillance of Endometrial Carcinoma

Tsutomu Kurihara, Hideki Mizunuma, Mitsuo Obara, +3

Gynecologic Oncology

Normal LevelMedicineGynecologyPathologyMenopause +6

A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy

Miki Ando, Toshinobu Nishimura, Satoshi Yamazaki, +14

Stem Cell Reports

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients

Masatoshi Sakurai, Hiroyoshi Kunimoto, Naohide Watanabe, +18

Leukemia

Induced Pluripotent Stem CellDevelopmental BiologyFpd/aml PatientsMedicineStem Cell Mobilization +6